Regulation of tumor growth by leukocyte-specific protein 1 in T cells

Background Clinical efficacy of T cell-based cancer immunotherapy is limited by the lack of T cell infiltration in the tumor mass, especially in solid tumors. Our group demonstrated previously that leukocyte-specific protein 1 (LSP1), an intracellular signal regulator, negatively regulates T cell in...

Full description

Bibliographic Details
Main Authors: Riri Kwon, Bong-Ki Hong, Kang-Gu Lee, Eunbyeol Choi, Laurent Sabbagh, Chul-Soo Cho, Naeun Lee, Wan-Uk Kim
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001180.full
id doaj-4b4c337489c24e3da813172adc83cfe7
record_format Article
spelling doaj-4b4c337489c24e3da813172adc83cfe72021-07-13T15:01:26ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-07-018210.1136/jitc-2020-001180Regulation of tumor growth by leukocyte-specific protein 1 in T cellsRiri Kwon0Bong-Ki Hong1Kang-Gu Lee2Eunbyeol Choi3Laurent Sabbagh4Chul-Soo Cho5Naeun Lee6Wan-Uk Kim7Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Microbiology, Infectiology, and Immunology, University of Montreal, Montreal, Quebec, CanadaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of KoreaBackground Clinical efficacy of T cell-based cancer immunotherapy is limited by the lack of T cell infiltration in the tumor mass, especially in solid tumors. Our group demonstrated previously that leukocyte-specific protein 1 (LSP1), an intracellular signal regulator, negatively regulates T cell infiltration in inflamed tissues.Methods To determine the immuno-regulatory effects of LSP1 in T cells on tumor progression, we investigated the growth of B16 melanoma in Lsp1 knockout (KO) mice and T cell-specific Lsp1 transgenic (Tg) mice. The immune cell subpopulation infiltrated into the tumor mass as well as the expression of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in T cells was assessed by flow cytometry and/or immunohistochemistry. Chemotactic migration was assayed with Lsp1 KO and Lsp1 Tg T cells. Adoptive transfer of Lsp1 KO or Lsp1 Tg T cells was performed in B16 melanoma-challenged Rag1 KO mice.Results Lsp1 KO mice showed decreased growth of B16 melanoma and increased infiltration of T cells in the tumor mass, which were completely reversed in T cell-specific Lsp1 Tg mice. Lsp1 KO CD8+ T cells also exhibited elevated migratory capacity in response to CXCL9 and CXCL10, whereas Lsp1 Tg CD8+ T cells did the opposite. LSP1 expression was increased in tumor-infiltrating T cells and could be induced by T cell receptor activation. Intriguingly, gene expression profiling of Lsp1 KO T cells suggested enhanced cytotoxicity. Indeed, expression of IFN-γ and TNF-α was increased in tumor-infiltrating CD4+ and CD8+ T cells of Lsp1 KO mice, while it was markedly reduced in those of Lsp1 Tg mice. Adoptive transfer of Lsp1 KO T cells to Rag1 KO mice was more effective in suppressing melanoma growth than transfer of Lsp1 Tg T cells. Of note, when treated with antiprogrammed cell death protein 1 (PD-1) antibody, inhibition of melanoma growth was more pronounced in Lsp1 KO mice than in Lsp1-sufficient mice, suggesting that Lsp1 depletion additively increases the antitumor effects of anti-PD-1 antibody.Conclusions LSP1 in T cells regulates the growth of B16 melanoma in mice, possibly by affecting migration and infiltration of T cells into the tumor and by modulating production of antitumor effector cytokines by CD8+ T cells. These findings provide evidence that LSP1 can be a target to improve the efficacy of T cell-based immunotherapy.https://jitc.bmj.com/content/8/2/e001180.full
collection DOAJ
language English
format Article
sources DOAJ
author Riri Kwon
Bong-Ki Hong
Kang-Gu Lee
Eunbyeol Choi
Laurent Sabbagh
Chul-Soo Cho
Naeun Lee
Wan-Uk Kim
spellingShingle Riri Kwon
Bong-Ki Hong
Kang-Gu Lee
Eunbyeol Choi
Laurent Sabbagh
Chul-Soo Cho
Naeun Lee
Wan-Uk Kim
Regulation of tumor growth by leukocyte-specific protein 1 in T cells
Journal for ImmunoTherapy of Cancer
author_facet Riri Kwon
Bong-Ki Hong
Kang-Gu Lee
Eunbyeol Choi
Laurent Sabbagh
Chul-Soo Cho
Naeun Lee
Wan-Uk Kim
author_sort Riri Kwon
title Regulation of tumor growth by leukocyte-specific protein 1 in T cells
title_short Regulation of tumor growth by leukocyte-specific protein 1 in T cells
title_full Regulation of tumor growth by leukocyte-specific protein 1 in T cells
title_fullStr Regulation of tumor growth by leukocyte-specific protein 1 in T cells
title_full_unstemmed Regulation of tumor growth by leukocyte-specific protein 1 in T cells
title_sort regulation of tumor growth by leukocyte-specific protein 1 in t cells
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-07-01
description Background Clinical efficacy of T cell-based cancer immunotherapy is limited by the lack of T cell infiltration in the tumor mass, especially in solid tumors. Our group demonstrated previously that leukocyte-specific protein 1 (LSP1), an intracellular signal regulator, negatively regulates T cell infiltration in inflamed tissues.Methods To determine the immuno-regulatory effects of LSP1 in T cells on tumor progression, we investigated the growth of B16 melanoma in Lsp1 knockout (KO) mice and T cell-specific Lsp1 transgenic (Tg) mice. The immune cell subpopulation infiltrated into the tumor mass as well as the expression of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in T cells was assessed by flow cytometry and/or immunohistochemistry. Chemotactic migration was assayed with Lsp1 KO and Lsp1 Tg T cells. Adoptive transfer of Lsp1 KO or Lsp1 Tg T cells was performed in B16 melanoma-challenged Rag1 KO mice.Results Lsp1 KO mice showed decreased growth of B16 melanoma and increased infiltration of T cells in the tumor mass, which were completely reversed in T cell-specific Lsp1 Tg mice. Lsp1 KO CD8+ T cells also exhibited elevated migratory capacity in response to CXCL9 and CXCL10, whereas Lsp1 Tg CD8+ T cells did the opposite. LSP1 expression was increased in tumor-infiltrating T cells and could be induced by T cell receptor activation. Intriguingly, gene expression profiling of Lsp1 KO T cells suggested enhanced cytotoxicity. Indeed, expression of IFN-γ and TNF-α was increased in tumor-infiltrating CD4+ and CD8+ T cells of Lsp1 KO mice, while it was markedly reduced in those of Lsp1 Tg mice. Adoptive transfer of Lsp1 KO T cells to Rag1 KO mice was more effective in suppressing melanoma growth than transfer of Lsp1 Tg T cells. Of note, when treated with antiprogrammed cell death protein 1 (PD-1) antibody, inhibition of melanoma growth was more pronounced in Lsp1 KO mice than in Lsp1-sufficient mice, suggesting that Lsp1 depletion additively increases the antitumor effects of anti-PD-1 antibody.Conclusions LSP1 in T cells regulates the growth of B16 melanoma in mice, possibly by affecting migration and infiltration of T cells into the tumor and by modulating production of antitumor effector cytokines by CD8+ T cells. These findings provide evidence that LSP1 can be a target to improve the efficacy of T cell-based immunotherapy.
url https://jitc.bmj.com/content/8/2/e001180.full
work_keys_str_mv AT ririkwon regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT bongkihong regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT kanggulee regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT eunbyeolchoi regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT laurentsabbagh regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT chulsoocho regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT naeunlee regulationoftumorgrowthbyleukocytespecificprotein1intcells
AT wanukkim regulationoftumorgrowthbyleukocytespecificprotein1intcells
_version_ 1721305264288694272